ConcertAI Partners with NVIDIA, Unveils Advanced AI Tools for Oncology Research and Treatment

talkbio0Tagged , , , , , , , , ,

1. Partnership Announcement: ConcertAI has partnered with NVIDIA to develop new clinical simulations and AI tools for oncology research and treatment.
2. CARA AI Platform: The partnership will integrate NVIDIA's AI capabilities into ConcertAI's CARA AI platform, enhancing its predictive and generative AI solutions.
3. Multi-Modal Oncology Data: ConcertAI's extensive oncology data repository includes genomic, transcriptomic, digital pathology, digital radiology, clinical, and social determinants of health data, covering all 50 states.
4. Clinical Trials: The collaboration aims to improve clinical trial design and outcome prediction using generative AI tools, enhancing the efficiency and precision of clinical trials.
5. Patient Outcomes: The partnership aims to accelerate the improvement of patient outcomes by leveraging AI to drive innovation in healthcare.
6. ASCO Annual Meeting: ConcertAI presented a study at the 2024 ASCO Annual Meeting, demonstrating a 2x improvement in predicting patient availability for clinical trials using AI models.

Leave a Reply

Your email address will not be published. Required fields are marked *